Understanding how T cells target tumors in lung cancer
The antigen specificity of tumor-targeting T cells in non-small cell lung cancer
This study is looking at how to make your immune cells, called T cells, better at fighting non-small cell lung cancer by customizing them to target your specific tumors, and it may involve you giving a blood sample to help find the best treatment for you.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11085090 on NIH RePORTER |
What this research studies
This research investigates the specific ways in which T cells, a type of immune cell, can be directed to attack tumors in patients with non-small cell lung cancer. The project focuses on enhancing adoptive cell therapy, which involves modifying T cells to improve their ability to recognize and destroy cancer cells. Patients may be involved in providing blood samples to help identify the most effective T cell responses against their tumors. The research aims to develop personalized treatment strategies that could lead to better outcomes for lung cancer patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with non-small cell lung cancer who are seeking innovative treatment options.
Not a fit: Patients with other types of lung cancer or those who are not eligible for immunotherapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized immunotherapies for patients with non-small cell lung cancer.
How similar studies have performed: Previous research has shown promising results in using T cell therapies for various cancers, indicating that this approach has potential for success.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Lee, Mark N. — Yale University
- Study coordinator: Lee, Mark N.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.